市場調查報告書
商品編碼
1036183

全球血漿治療市場:按類型(純富血小板血漿/富血小板血漿纖維蛋白),按應用(整形外科/皮膚科/化妝品/風濕病/眼科),按最終用戶(醫院/診所/研究機構)預測至2028

Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes)- Forecast to 2028

出版日期: | 出版商: Meticulous Market Research Pvt. Ltd. | 英文 169 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球血漿治療市場預計將以 12.2% 的複合年增長率增長,到 2028 年將達到 8.825 億美元。

這種市場增長是由於富血小板血漿 (PRP) 治療的益處、PRP 治療意識的提高、肌肉骨骼、運動、骨科損傷增加以及全球整容手術增加等因素造成的。此外,新興市場增加的 PRP 治療和醫學進步預計將為提供富含血小板的血漿治療的公司提供重要的增長機會。然而,在預測期內,PRP 治療替代方案的可用性以及與 PRP 相關的副作用預計將在一定程度上限制富含血小板的血漿治療市場的增長。

本報告對全球血漿治療市場進行研究和分析,並提供市場動態、市場分析、競爭形勢和企業概況等系統資料。

目錄

第 1 章介紹

  • 市場定義
  • 市場生態系統
  • 貨幣
  • 主要利益相關者

第 2 章調查方法

  • 調查過程
  • 數據收集和驗證
    • 二次調查
    • 初步調查
  • 市場評估
    • 估計市場規模
    • 市場份額分析
  • 調查的先決條件
  • 調查範圍

第 3 章執行摘要

第 4 章市場洞察

  • 促進因素
    • 提供的好處:通過 PRP 治療
    • 提高對 PRP 療法的認識
    • 肌肉骨骼和運動損傷導致的患病率增加
    • 世界上越來越多的整容手術案例
  • 抑制因素
    • PRP 治療替代方案的可用性
    • 與使用 PRP 相關的副作用
  • 市場機會
    • 增加PRP治療的應用
    • 新興經濟體的醫療保健進展
  • 挑戰
    • 嚴格的 PRP 使用監管框架
  • 波特五力分析
    • 供應商的談判權
    • 買方的議價能力
    • 替代威脅
    • 新進入者的威脅
    • 競爭對手之間的敵對關係

第 5 章 COVID-19 對全球富含血小板的血漿市場的影響

第 6 章 PRP 認證標準

第 7 章 PRP 治療的市場趨勢

第 8 章富血小板血漿治療市場:按類型

  • 簡介
  • 純富含血小板的血漿
  • 富含血小板的血漿
  • 純聚血小板纖維蛋白
  • 多白細胞/血小板纖維蛋白 (L-PRF)

第 9 章富血小板血漿治療市場:按應用

  • 簡介
  • 骨科和外傷科
  • 類風濕性關節炎
  • 皮膚科/美容科
  • 眼科
  • 口腔頜面外科和牙科
  • 其他應用

第 10 章富血小板血漿治療市場:由最終用戶

  • 簡介
  • 醫院和診所
  • 調查

第 11 章富血小板血漿治療市場:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲

第 12 章競爭形勢

  • 簡介
  • 關鍵增長戰略
  • 市場份額分析(2020 年)
    • DePuy Synthes, Inc.(美國)
    • Stryker Corporation(美國)
    • Zimmer Biomet Holdings, Inc.(美國)
    • Terumo Corporation(日本)
  • 主要公司的SWOT分析
    • Zimmer Biomet Holdings, Inc.
    • Terumo Corporation
    • Arthrex, Inc.
    • DePuy Synthes, Inc.(Johnson & Johnson)
    • Stryker Corporation
  • 資金和贈款評估

第 13 章公司簡介

  • Arthrex, Inc.
    • 業務概覽
    • 產品組合
    • 戰略發展
  • DePuy Synthes, Inc.(強生公司)
    • 業務概覽
    • 財務概覽
    • 產品組合
  • Dr PRP USA LLC
    • 業務概覽
    • 產品組合
  • Emcyte Corporation
    • 業務概覽
    • 產品組合
    • 戰略發展
  • Exactech, Inc.
    • 業務概覽
    • 財務概覽
    • 產品組合
  • Global Stem Cells Group, Inc.
    • 業務概覽
    • 產品組合
    • 戰略發展
  • Celling Biosciences, Inc
    • 業務概覽
    • 產品組合
  • Terumo Corporation
    • 業務概覽
    • 財務概覽
    • 產品組合
  • Regen Lab SA
    • 業務概覽
    • 產品組合
  • Stryker Corporation
    • 業務概覽
    • 財務概覽
    • 產品組合
    • 戰略發展
  • Zimmer Biomet Holdings, Inc.
    • 業務概覽
    • 財務概覽
    • 產品組合
  • Juventix Regenerative Medical, Llc
    • 業務概覽
    • 產品組合

第 14 章附錄

  • 問卷
  • 可用的自定義
目錄
Product Code: MRHC -104530

Global Platelet Rich Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes)-Forecast to 2028

The global platelet rich plasma (PRP) therapy market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028.

Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.

The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness toward PRP therapies, rising prevalence of musculoskeletal, sports, & orthopedic injuries, and the growing number of cosmetic procedures worldwide.

In addition, increasing PRP treatments and advancing healthcare in emerging economies are expected to offer significant growth opportunities for platelet rich plasma therapy providers.

However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.

Based on type, the global platelet rich plasma therapy market is segmented into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte & platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Pure PRP is advantageous over conventional PRP as it undergoes a two-step concentration process that eliminates red blood cells and neutrophils. Thus, the advantages offered by pure PRP treatment over other pain-relieving and cosmetic treatments are expected to augment the segment's growth during the coming years.

Based on application, the platelet rich plasma therapy market is segmented into orthopedics & traumatology, rheumatology, dermatology and cosmetology, ophthalmology, stomatology and odontology, and other applications. In 2021, the orthopedics and traumatology segment is estimated to account for the largest share of the global platelet rich plasma therapy market. The increasing number of patients suffering from musculoskeletal disorders and increasing recommendation of PRP therapy as a parallel treatment of various disorders such as fractures and chronic pain is expected to drive the demand for PRP for orthopedics and traumatology application in the market.

Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to the usage of platelet rich plasma therapy by hospitals and clinics for pain management, regenerative medicines, joints & bone surgeries, cosmetic enhancements, hair growth, and sports injuries. PRP treatments are mostly applied to manage accidents and trauma, infectious diseases, orthopedic treatments, cosmetics, dermatology, and hair growth & transplant.

An in-depth analysis of the geographical scenario of the platelet-rich plasma therapy market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global platelet-rich plasma therapy market in 2021, followed by Europe and Asia-Pacific.

Key companies operating in the global platelet rich plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).

Scope of the Report

Global Platelet Rich Plasma Therapy Market, by Type

  • Pure Platelet rich Plasma
  • Leukocyte-rich PRP
  • Platelet-rich Fibrin
  • Leukocyte & Platelet rich Fibrin

Global Platelet Rich Plasma Therapy Market, by Application

  • Orthopedics and Traumatology
  • Dermatology and Cosmetology
  • Rheumatology
  • Stomatology and Odontology
  • Ophthalmology
  • Others

Global Platelet Rich Plasma Therapy Market, by End User

  • Hospitals and Clinics
  • Research Institutes

Global Platelet Rich Plasma Therapy Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for this Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Drivers
    • 4.1.1. Advantages Offered by PRP Treatment
    • 4.1.2. Increasing Awareness Toward PRP Therapies
    • 4.1.3. Rising Prevalence of Musculoskeletal and Sports Injuries
    • 4.1.4. Growing Number of Cosmetic Procedures Worldwide
  • 4.2. Restraints
    • 4.2.1. Availability of Alternatives for PRP Treatment
    • 4.2.2. Side-Effects Associated with the Use of PRP
  • 4.3. Opportunities
    • 4.3.1. Increasing Applications of PRP Treatments
    • 4.3.2. Advancing Healthcare in Emerging Economies
  • 4.4. Challenge
    • 4.4.1. Stringent Regulatory Framework for the Use of PRP
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of Substitutes
    • 4.5.4. Threat of New Entrants
    • 4.5.5. Competitive Rivalry

5. Impact of COVID-19 on the Global Platelet Rich Plasma Market

6. PRP Qualification Criteria

7. PRP Therapy Market Trends

8. Platelet Rich Plasma Therapy Market, by Type

  • 8.1. Introduction
  • 8.2. Pure PRP
  • 8.3. Leukocyte-Rich PRP
  • 8.4. Pure Platelet Rich Fibrin
  • 8.5. Leukocyte And Platelet Rich Fibrin (L-PRF)

9. Platelet Rich Plasma (PRP) Therapy Market, by Application

  • 9.1. Introduction
  • 9.2. Orthopedics & Traumatology
  • 9.3. Rheumatology
  • 9.4. Dermatology & Cosmetology
  • 9.5. Opthalmology
  • 9.6. Stomatology & Odontology
  • 9.7. Other Applications

10. Platelet Rich Plasma Therapy Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Clinics
  • 10.3. Research Institutes

11. Platet Rich Plasma Therapy Market, by Geography

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
    • 11.3.1. Germany
    • 11.3.2. France
    • 11.3.3. U.K.
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe (RoE)
  • 11.4. Asia-Pacific
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Rest of Asia-Pacific (RoAPAC)
  • 11.5. Latin America
    • 11.5.1. Brazil
    • 11.5.2. Mexico
    • 11.5.3. Argentina
    • 11.5.4. Rest of Latin America
  • 11.6. Middle East & Africa

12. Competitive Landscape

  • 12.1. Introduction
  • 12.2. Key Growth Strategies
  • 12.3. Market Share Analysis (2020)
    • 12.3.1. DePuy Synthes, Inc. (U.S.)
    • 12.3.2. Stryker Corporation (U.S.)
    • 12.3.3. Zimmer Biomet Holdings, Inc. (U.S.)
    • 12.3.4. Terumo Corporation (Japan).
  • 12.4. Key Players SWOT Analysis
    • 12.4.1. Zimmer Biomet Holdings, Inc.
      • 12.4.1.1. Strengths
      • 12.4.1.2. Weaknesses
      • 12.4.1.3. Opportunities
      • 12.4.1.4. Threats
    • 12.4.2. Terumo Corporation
      • 12.4.2.1. Strengths
      • 12.4.2.2. Weaknesses
      • 12.4.2.3. Opportunities
      • 12.4.2.4. Threats
    • 12.4.3. Arthrex, Inc.
      • 12.4.3.1. Strengths
      • 12.4.3.2. Weaknesses
      • 12.4.3.3. Opportunities
      • 12.4.3.4. Threats
    • 12.4.4. DePuy Synthes, Inc. (Johnson &Johnson)
      • 12.4.4.1. Strengths
      • 12.4.4.2. Weaknesses
      • 12.4.4.3. Opportunities
      • 12.4.4.4. Threats
    • 12.4.5. Stryker Corporation
      • 12.4.5.1. Strengths
      • 12.4.5.2. Weaknesses
      • 12.4.5.3. Opportunities
      • 12.4.5.4. Threats
  • 12.5. Funding and Grants Assessment

13. Company Profiles

  • 13.1. Arthrex, Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Product Portfolio
    • 13.1.3. Strategic Developments
  • 13.2. DePuy Synthes, Inc. (Johnson & Johnson)
    • 13.2.1. Business Overview
    • 13.2.2. Financial Overview
    • 13.2.3. Product Portfolio
  • 13.3. Dr PRP USA LLC
    • 13.3.1. Business Overview
    • 13.3.2. Product Portfolio
  • 13.4. Emcyte Corporation
    • 13.4.1. Business Overview
    • 13.4.2. Product Portfolio
    • 13.4.3. Strategic Developments
  • 13.5. Exactech, Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Financial Overview
    • 13.5.3. Product Portfolio
  • 13.6. Global Stem Cells Group, Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Product Portfolio
    • 13.6.3. Strategic Developments
  • 13.7. Celling Biosciences, Inc
    • 13.7.1. Business Overview
    • 13.7.2. Product Portfolio
  • 13.8. Terumo Corporation
    • 13.8.1. Business Overview
    • 13.8.2. Financial Overview
    • 13.8.3. Product Portfolio
  • 13.9. Regen Lab SA
    • 13.9.1. Business Overview
    • 13.9.2. Product Portfolio
  • 13.10. Stryker Corporation
    • 13.10.1. Business Overview
    • 13.10.2. Financial Overview
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Developments
  • 13.11. Zimmer Biomet Holdings, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Financial Overview
    • 13.11.3. Product Portfolio
  • 13.12. Juventix Regenerative Medical, Llc
    • 13.12.1. Business Overview
    • 13.12.2. Product Portfolio

14. Appendix

  • 14.1. Questionnaire
  • 14.2. Available Customization

List of Tables

  • Table 1 Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021-2028)
  • Table 2 Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
  • Table 3 Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021-2028)
  • Table 4 Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
  • Table 5 Current Indications for Which PRP Therapy Is Used
  • Table 6 Ongoing Research in New Medical Fields Regarding PRP Therapy
  • Table 7 Global Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 8 Global Pure PRP Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 9 Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 10 Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 11 Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 12 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 13 List of Clinical Trials with PRP for Orthopedic Applications
  • Table 14 Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
  • Table 15 Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019-2028 (USD Million)
  • Table 16 Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
  • Table 17 Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019-2028 (USD Million)
  • Table 18 List of Research Trials for Dermatology & Cosmetology
  • Table 19 Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
  • Table 20 Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019-2028 (USD Million)
  • Table 21 Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
  • Table 22 Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019-2028 (USD Million)
  • Table 23 Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
  • Table 24 Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019-2028 (USD Million)
  • Table 25 Clinical Trials with PRP Therapy in Other Applications
  • Table 26 Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
  • Table 27 Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019-2028 (USD Million)
  • Table 28 Global Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 29 Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019-2028 (USD Million)
  • Table 30 Various Ongoing Researches for Platelet Rich Plasma
  • Table 31 Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019-2028 (USD Million)
  • Table 32 Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 33 North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019-2028 (USD Million)
  • Table 34 North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 35 North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 36 North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 37 U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 38 U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 39 U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 40 Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 41 Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 42 Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 43 Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 44 Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 45 Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 46 Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 47 Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 48 Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 49 Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 50 France: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 51 France: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 52 France: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 53 U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 54 U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 55 U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 56 Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 57 Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 58 Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 59 Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 60 Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 61 Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019-2028 (USD Million)
  • Table 62 Fertility Rate total (Birth Per Woman)
  • Table 63 RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 64 RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 65 RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 66 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 67 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 68 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 69 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 70 Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 71 Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 72 Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 73 China: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 74 China: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 75 China: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 76 India: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 77 India: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 78 India: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 79 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 80 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 81 RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 82 Health Expenditure Per Capita In Latin American Countries
  • Table 83 Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 84 Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 85 Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 86 Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 87 Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 88 Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 89 Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 90 Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 91 Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 92 Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 93 Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 94 Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 95 Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 96 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 97 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 98 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 99 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019-2028 (USD Million)
  • Table 100 Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019-2028 (USD Million)
  • Table 101 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019-2028 (USD Million)
  • Table 102 Number of Developments by the Major Players During 2018-2021
  • Table 103 Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
  • Table 104 Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
  • Figure 8 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
  • Figure 9 Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
  • Figure 10 Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
  • Figure 11 Market Dynamics
  • Figure 12 Porter's Five forces Analysis: Platelet Rich Plasma Therapy Market
  • Figure 13 Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
  • Figure 14 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
  • Figure 15 Global Platelet Rich Plasma Therapy Market Size, by End User, 2021-2028 (USD Million)
  • Figure 16 Number of Research Published over The Years for Platelet Rich Plasma Therapy
  • Figure 17 Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021-2028 (USD Million)
  • Figure 18 North America: Platelet Rich Plasma Therapy Market Snapshot
  • Figure 19 Europe: Platelet Rich Plasma Therapy Market Snapshot
  • Figure 20 Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
  • Figure 21 Key Growth Strategies Adopted by Leading Players -2018-2021
  • Figure 22 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
  • Figure 23 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
  • Figure 24 Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
  • Figure 30 National Institute of Health, U.S. Funding for Regenerative Medicines, 2013-2022 (USD Million)
  • Figure 31 Johnson And Johnson: Financial Overview, 2020
  • Figure 32 Terumo Corporation.: Financial Overview, 2020
  • Figure 33 Stryker Corporation.: Financial Overview, 2020
  • Figure 34 Zimmer Biomet Holdings, Inc: Financial Overview, 2020